March 25, 2011
A Delaware federal judge ruled on Thursday that Watson Pharmaceuticals Inc.'s proposed generic version of Fentora infringes Cephalon Inc.'s patent for the painkiller, handing Cephalon a big victory days after the court invalidated two related patents.